Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 2

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-6-5

Curated date: 2024/04/18

Curator: Victoria

Revision editor(s): Victoria, Aleru Divine

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Surface of tongue Tongue surface,Surface of tongue,surface of tongue
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
COVID-19 2019 novel coronavirus,2019 novel coronavirus infection,2019-nCoV,2019-nCoV infection,beta-CoV,beta-CoVs,betacoronavirus,coronavirus disease 2019,SARS-coronavirus 2,SARS-CoV-2,severe acute respiratory syndrome coronavirus 2,severe acute respiratory syndrome coronavirus 2 infectious disease,β-coronavirus,β-CoV,β-CoVs,COVID-19,cOVID-19
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Controls and Post-Covid-19 Groups
Group 1 name Corresponds to the case (exposed) group for case-control studies
Covid-19 Group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Participants in this group were COVID-19 patients.
Group 0 sample size Number of subjects in the control (unexposed) group
154
Group 1 sample size Number of subjects in the case (exposed) group
71
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
8 weeks

Lab analysis

Sequencing type
ITS / ITS2
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
3
Matched on Factors on which subjects have been matched on in a case-control study
age, sex


Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-6-5

Curated date: 2024/04/19

Curator: Victoria

Revision editor(s): Victoria, Aleru Divine

Source: Figure 4g

Description: This figure shows the predominant oral fungal among the COVID-19, Post-COVID-19, and control groups.

Abundance in Group 1: increased abundance in Covid-19 Group

NCBI Quality ControlLinks
Acrodictys
Acrodictys fluminicola
Aspergillus subflavus
Chrysosphaeria jannelii
Chrysosphaeria
Hydnobolites
Hydnobolites roseus
Saccharomyces cerevisiae
Angustimassarina camporesii
Simplicillium sympodiophorum
Simplicillium
Angustimassarina
Entorrhiza
Parasympodiella longispora
Filobasidiaceae gen Incertae sedisFilobasidiaceae gen Incertae sedis
Tuber alcaracense
Fantasmomyces hyalinus
Fantasmomyces
Parasympodiella
Parafuscosporella
[Cryptococcus] ater
Vanakripa mucosa
Tuber
Candida spe Incertae sedisCandida spe Incertae sedis
Saccharomyces

Revision editor(s): Victoria, Aleru Divine